STOCK TITAN

Albemarle (ALB) SVP Cynthia Lima receives 1,796-share stock grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Albemarle Corporation reported that senior vice president Cynthia Renee Lima received an equity award of 1,796 shares of common stock as a grant or other acquisition. The award was priced at $0.00 per share, increasing her directly held stake to 14,438 shares. According to the terms, these restricted stock units vest 100% on March 2, 2029, tying a portion of her compensation to the company’s long-term performance.

Positive

  • None.

Negative

  • None.
Insider Lima Cynthia Renee
Role SVP, Ext. Affairs & Comm.
Type Security Shares Price Value
Grant/Award Common Stock 1,796 $0.00 --
Holdings After Transaction: Common Stock — 14,438 shares (Direct)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lima Cynthia Renee

(Last) (First) (Middle)
4250 CONGRESS ST
SUITE 900

(Street)
CHARLOTTE NC 28209

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Ext. Affairs & Comm.
3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/02/2026 A 1,796(1) A $0 14,438 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted Stock Units vest 100% on 03/02/2029, subject to the terms of the award agreement.
Remarks:
/s/ Corey E. Tanner, Attorney-in-fact 03/04/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ALB senior vice president Cynthia Renee Lima report?

Cynthia Renee Lima reported receiving an equity award of 1,796 shares of Albemarle common stock. The transaction was coded as a grant or other acquisition, reflecting compensation rather than an open-market purchase, and increased her directly held stake to 14,438 shares.

Was the Albemarle (ALB) insider award to Cynthia Renee Lima a purchase or a grant?

The Albemarle transaction was a grant or award acquisition, not a market purchase. It was reported under code A, with 1,796 shares at a price of $0.00 per share, indicating stock-based compensation rather than cash-funded buying of shares.

How many Albemarle (ALB) shares does Cynthia Renee Lima own after this Form 4 transaction?

After the reported transaction, Cynthia Renee Lima directly holds 14,438 shares of Albemarle common stock. This total reflects the addition of 1,796 shares from the equity award, as disclosed in the Form 4 insider filing for the non-derivative common stock transaction.

What are the vesting terms for Cynthia Renee Lima’s Albemarle restricted stock units?

The restricted stock units granted to Cynthia Renee Lima vest 100% on March 2, 2029. Vesting means she will fully earn the 1,796-share award on that date, provided the conditions in the award agreement are satisfied, aligning compensation with long-term company performance.

What transaction code and direction were disclosed in the Albemarle (ALB) Form 4?

The Form 4 used transaction code A, meaning a grant, award, or other acquisition. The normalized direction is “acquire,” applied to 1,796 shares of Albemarle common stock, and the filing shows no insider sales or dispositions in this particular report.